Skip to main content
Log in

A novel MSH2 germline mutation in a Druze HNPCC family

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Germline mutations in DNA mismatch repair (DNA-MMR) genes, mainly MLH1, MSH2, and MSH6, underlie Hereditary non-polyposis colorectal cancer (HNPCC) and are mostly family-specific, with few reported founder mutations in MSH2 (Ashkenazim) MLH1 (Finnish). No mutations in colon cancer susceptibility genes have ever been reported in Druze individuals, a Moslem related faith encompassing ∼1,000,000 individuals worldwide. A novel MSH2 mutation is described in a Druze HNPCC family: a multigenerational family with 10 members in 4 generations affected with colorectal cancer (mean age of diagnosis 46.5 years), two with gastric cancer and one—endometrial cancer. Mutational analysis of the MSH2 gene using denaturing gradient gel electrophoresis (DGGE) and direct sequencing revealed the c.702delA mutation in codon 234 of exon 4 of the MSH2 gene leading to a premature early stop in codon 245, p.Thr234fsX245. Analysis of mutation-carrying or presumed carriers individuals’ offspring, revealed 11/42 asymptomatic mutation carriers, age range 17–50 years. The mutation was not present in two additional Druze HNPCC families and 20 Druze sporadic colon cancer patients. This is the first mutation ever reported in a colon cancer susceptibility gene in a Druze family and it appears not to be a founder mutation in Druze individuals with HNPCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Berends MJ, Wu Y, Sijmons RH et al (2002) Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet 70:26–37

    Article  PubMed  CAS  Google Scholar 

  2. Lynch HT, Smyrk T (1996) Hereditary nonpolyposis colorectal cancer (lynch syndrome) an updated review. Cancer 78:1149–1167

    Article  PubMed  CAS  Google Scholar 

  3. Aaltonen LA, Salovaara R, Kristo P et al (1998) Incidence of HNPCC and the feasibility of molecular screening for the disease. N Engl J Med 338:1481–1487

    Article  PubMed  CAS  Google Scholar 

  4. Vasen HF, Mecklin JP, Meera-Khan P et al (1991) The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34:424–425

    Article  PubMed  CAS  Google Scholar 

  5. Vasen HF, Watson P, Mecklin JP et al (1999) New clinical criteria for HNPCC proposed by the ICG on HNPCC. Gastroenterology 116:1453–1456

    Article  PubMed  CAS  Google Scholar 

  6. Peltomaki P, Vasen HF (1997) Mutations predisposing to HNPCC: database and results of a collaborative study. The international collaborative group on HNPCC. Gastroenterology 113:1146–1158

    CAS  Google Scholar 

  7. Nicolaides NC, Papadopoulos N, Liu B et al (1994) Mutations of two PMS homologues in hereditary non polyposis colorectal cancer. Nature 371:75–80

    Article  PubMed  CAS  Google Scholar 

  8. Akiyama Y, Sato H, Yamada T et al (1997) Germline mutation of the MSH6/GTBP gene in an atypical hereditary non-polyposis colorectal cancer kindred. Cancer Res 57:3920–3923

    PubMed  CAS  Google Scholar 

  9. Miyaki M, Konishi M, Tanaka K et al (1997) Germline mutation of MSH6 as the cause of hereditary non polyposis colorectal cancer. Nat Genet 17:271–272

    Article  PubMed  CAS  Google Scholar 

  10. Kolodner RD, Tytell JD, Schmeits JL et al (1999) Germ line MSH6 mutations in colorectal cancer families. Cancer Res 59:5068–5074

    PubMed  CAS  Google Scholar 

  11. Wijnen J, de Leeuw W, Vasen H et al (1993) Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 23:142–144

    Article  Google Scholar 

  12. Wu Y, Berends MJ, Mensink RG et al (1999) Association of hereditary non polyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 65:1291–1298

    Article  PubMed  CAS  Google Scholar 

  13. Wagner A, Barrows A, Wijnen JT et al (2003) Molecular analysis of hereditary non polyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletions of the MSH2 gene. Am J Hum Genet 72:1088–1100

    Article  PubMed  CAS  Google Scholar 

  14. Foulkes WD, Thiffault I, Gruber SB et al (2002). The founder mutation MSH2*1906G→C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet 71:1395–1412

    Article  PubMed  CAS  Google Scholar 

  15. Guillem JG, Moore HG, Palmer C et al (2004) A636P testing in Ashkenazi Jews. Fam Cancer 3:223–227

    Article  PubMed  CAS  Google Scholar 

  16. Nystrom-Lahti M, Kristo P, Nicolaides NC et al (1995) Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med 1:1203–1206

    Article  PubMed  CAS  Google Scholar 

  17. Moisio AL, Sistonen P, Weissenbach J et al (1996) Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer. Am J Hum Genet 59:1243–1251

    PubMed  CAS  Google Scholar 

  18. Lynch HT, Coronel SM, Okimoto R et al (2004) A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States. JAMA 291:718–724

    Article  PubMed  CAS  Google Scholar 

  19. Vardi-Saliternik R, Friedlander Y, Cohen T (2002) Consanguinity in a population sample of Israeli Muslim Arabs, Christian Arabs and Druze. Ann Hum Biol 29:422–431

    Article  PubMed  CAS  Google Scholar 

  20. Gross DJ, Avishai N, Meiner V et al (1996) Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene. J Clin Endocrinol Metab 81:147–149

    Article  PubMed  CAS  Google Scholar 

  21. Wu Y, Nystrom-Lahti M, Osinga J et al (1997) MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosomes Cancer 18:269–278

    Article  PubMed  CAS  Google Scholar 

  22. Gille JJ, Hogervost FB, Pals G, et al (2002) Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 87:892–897

    Article  PubMed  CAS  Google Scholar 

  23. Syngal S, Fox EA, Li C et al (1999) Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. JAMA 282:247–253

    Article  PubMed  CAS  Google Scholar 

  24. Kouraklis G, Misiakos EP (2005) Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management. Dig Dis Sci 50:336–344

    Article  PubMed  Google Scholar 

  25. Ponz de Leon M, Benatti P, Di Gregorio C et al (2004) Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Br J Cancer 90:882–887

    Article  Google Scholar 

  26. Wagner A, van Kessel I, Kriege MG et al (2005) Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Fam Cancer 4:295–300

    Article  PubMed  Google Scholar 

  27. Halbert CH, Lynch H, Lynch J et al (2004) Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med 164:1881–1887

    Article  PubMed  Google Scholar 

  28. Strate LL, Syngal S (2005) Hereditary colorectal cancer syndromes. Cancer Causes Control 16:201–213

    Article  PubMed  Google Scholar 

  29. Watson P, Riley B (2005) The tumor spectrum in the Lynch syndrome. Fam Cancer 4:245–248

    Article  PubMed  Google Scholar 

  30. Park YJ, Shin KH, Park JG (2000) Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea. Clin Cancer Res 6:2994–2998

    PubMed  CAS  Google Scholar 

  31. Lucci-Cordisco E, Zito I, Gensini F et al (2003) Hereditary nonpolyposis colorectal cancer and related conditions. Am J Med Genet A 122:325–334

    Article  Google Scholar 

  32. Fares F, Axelord Ran S, David M et al (2004) Identification of two mutations for ataxia telangiectasia among the Druze community. Prenat Diagn 24:358–362

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was in part sponsored by a grant from the Israel cancer association (ICA) to E.F.; This work was done in part as fulfillment for the studies for a graduate degree from the University of Groningen, The Netherlands by Renée C. Niessen.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eitan Friedman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zidan, J., Niessen, R.C., Laitman, Y. et al. A novel MSH2 germline mutation in a Druze HNPCC family. Familial Cancer 7, 135–139 (2008). https://doi.org/10.1007/s10689-007-9157-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-007-9157-5

Keywords

Navigation